[{"name":"Switching to a second-line treatment (ID 765)","mode":"","is_cme":false,"info":{"presentation":"Switching to a second-line treatment <small>(ID 765)<\/small>","session":"Novartis - Industry Satellite Symposium: The Power of Choice in HR+, HER2–Advanced Breast Cancer: A Case Continuum <small>(ID 84)<\/small>","presenter":"Hans-Christian Kolberg<small> (Bottrop, Germany)<\/small>","photo":null},"playlist":[{"name":"Switching to a second-line treatment","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/84\/v\/765_2c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/84\/v\/765_2c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/84\/v\/765_2c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/84\/v\/765_2c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"6L240ec02Vk"}